Oftentimes, jaundice in newborn babies may be caused by an underlying medical condition. However, it is often not a serious problem, and there are many different treatment options available. If your baby has jaundice, it is important to take the necessary steps to treat the problem, so that your baby can lead a healthy life.
Depending on the cause, treatment options for jaundice in newborn babies may include blood transfusion, intravenous immunoglobulin, or phototherapy. These treatments are aimed at reducing the bilirubin level in the blood. While they are effective, they may have side effects. In addition, they are generally not recommended for full-term healthy infants.
Blood transfusion involves replacing the baby’s blood with blood from a donor. This treatment is usually only needed when the bilirubin level is too high. The transfusion may take several hours and may need to be repeated. This treatment is also usually not needed if the jaundice is mild.
Phototherapy is a treatment that uses light to help the liver break down bilirubin. The baby’s skin is exposed to a special blue-green light that makes it easier for the liver to break down bilirubin. This treatment is effective and may be used to treat a baby’s jaundice.
Infants with jaundice may be offered intravenous immunoglobulin, which is an injectable medication that blocks antibodies from attacking red blood cells. This medication may also be used to treat babies who have incompatibility with their mother’s blood type.
Phototherapy is generally very effective and can be used to treat a baby’s high bilirubin levels. Medical staff will protect the baby’s eyes and allow it to lie in a light for a few hours. In severe cases, phototherapy may be used multiple times to help the baby’s bilirubin level go down. The medical staff will check the baby’s bilirubin levels every six to twelve hours until the bilirubin level has gone down to a safe level.
A blood transfusion is used in severe cases of jaundice. This treatment replaces the baby’s blood with a blood type that is the same as the baby’s own. The bilirubin level goes down quickly after the transfusion, but if the baby is sick, the transfusion may need to be repeated. The blood may be from a matching donor or a donor who has the same blood type as the baby.
Jaundice in newborn babies is a common condition that is often harmless. If you notice any signs or symptoms of jaundice in your baby, contact your healthcare provider immediately.
Among the many causes of anemia, hemolytic anemia is one that can have devastating effects on the baby. It is a temporary disorder that occurs when the body produces less blood than it needs. The disease can cause fever and paleness. Some babies need blood transfusions in the first two months of life.
In some cases, hemolytic anemia can be caused by autoimmune conditions. The disease occurs when the immune system attacks the red blood cells in the baby’s body. It can also occur after an infection. The immune system thinks that the baby’s red blood cells are foreign and destroys them.
The first successful treatment for hemolytic disease of the newborn was developed in the 1940s. The procedure involved injecting the baby with intravenous immunoglobulin, which contains antibodies from blood donors. This medication lowers bilirubin levels. It also helps to prevent red blood cells from being destroyed.
An exchange transfusion is also used to treat hemolytic anemia. The baby’s blood is replaced with blood that has a normal bilirubin level. This transfusion procedure is typically done at a hospital’s NICU.
In the NICU, a neonatologist will examine the baby for symptoms of anemia and other conditions. He will also assess the baby’s breathing and heart rate. If he notices any problems, he will order a blood test to look for anemia. The test will also look for iron and bilirubin.
Anemia can cause severe jaundice, which can affect the baby’s hearing. If the anemia is severe, the baby may be at risk for hydrops fetalis. This is a condition that can result in a stillbirth. Hemolytic anemia can also cause brain damage. Symptoms may be similar to other blood disorders. If the baby has anemia, it is recommended that he avoid cold weather. It is also important to wear warm clothes.
HDFN is also known as hemolytic disease of the fetus and newborn. It occurs when the mother’s blood has antibodies that attack the red blood cells of the baby. These antibodies cross the placenta. The baby’s red blood cells are destroyed quickly. The disease is relatively uncommon in the United States.
Glucose-6-phosphate-dehydrogenase deficiency is an inherited disorder that causes acute hemolytic anemia. It affects 400 million people worldwide, primarily in Southeast Asia and sub-Saharan Africa. This disease causes the premature breakdown of red blood cells, which can lead to anemia, pale skin, lethargy, and rapid heart rate. Some people with this disease may require blood transfusions to prevent a life-threatening condition called hemolysis.
Glucose-6-phosphate-dehydrogenase is a housekeeping enzyme that keeps red blood cells healthy. When this enzyme is not produced in the body, the red blood cells may break down too quickly, causing neonatal jaundice. Jaundice is characterized by yellow-orange discoloration of the skin. The presence of jaundice can sometimes lead to critical levels of bilirubin, which can cause death.
In a study conducted in Egypt, the incidence of neonatal jaundice was found to be associated with G-6-PD deficiency. A previous review of the literature found that 8.9% of newborn babies with jaundice had G6PD deficiency. In this study, the incidence of neonatal jaundice in G-6-PD deficiency was found to be higher than the incidence of neonatal jaundice among G-6-PD normal infants.
The study was conducted at three Egyptian neonatal and pediatric centers. Blood samples were collected at 0-10 days of age when infants had clinically apparent jaundice. The serum bilirubin levels of infants with hyperbilirubinemia were compared with those of G-6-PD normal infants. The results showed that the G6PD deficient infants presented earlier than G6PD normal infants. Moreover, the severity of jaundice was also more common in G-6-PD deficient infants than in G-6-PD normal infants.
A total of 487 neonates with indirect hyperbilirubinemia were included in this study. Among these infants, 32 were deficient in G-6-PD. Using PCR-RFLP analysis, a G6PD gene sequencing analysis was performed on these infants. PCR-RFLP analysis showed that the infants with G6PD deficiency had a higher reticulocyte count and hemoglobin than G6PD normal infants. In addition, the infants with G6PD deficiency took 1.6 +- 1.3 days to develop peak jaundice, while G6PD normal infants took 2.2 +- 2.2 days.
The authors thank the participants for their participation in the study. In addition, they thank the study team for their efforts in collecting data.
Normally, breastmilk jaundice in newborn babies will go away after the first two weeks of life. Jaundice may last longer if the baby is not getting enough milk or if there are other factors. The infant may need extra feeds or may need to be switched to formula.
In some infants, high bilirubin levels are a serious concern. This condition, called hyperbilirubinemia, occurs in babies born prematurely or with an underlying medical condition. Typically, these infants need to have regular follow-up visits with a doctor.
In some cases, breast milk jaundice in newborn babies can be treated with phototherapy. This involves keeping the baby under a special light for a day or two. The light changes the structure of bilirubin molecules, making them more easily removed. Most babies are able to handle this treatment without any problems. However, some babies will lose fluid during the treatment.
Newborns with jaundice may have yellow eyes, skin, or hair. They may also be at increased risk of developing kernicterus, a condition that can permanently damage the brain.
During phototherapy, the baby will wear protective glasses to prevent eye damage. The baby will also be able to access milk more easily. The special light will make the bilirubin molecules easier to remove, and it is hoped that this will help clear jaundice.
Breastfeeding should be encouraged as early as possible. It can help improve the mother’s milk supply, and the baby may be able to produce more bowel movements. Feeding more often will help the baby clear jaundice more quickly. Having more bowel movements will also help the baby pass more meconium, which is a large part of the reason why bilirubin accumulates in the body.
It is not known why breast milk jaundice in newborn babies occurs. Many doctors believe it is due to a substance found in breast milk that can interfere with the liver’s ability to process bilirubin.
Breastfeeding jaundice in newborn babies is usually mild and will go away with proper treatment. If the jaundice is not going away, it is a good idea to see a lactation consultant or child and family health nurse. They can help you with breastfeeding techniques and make sure the baby is latching onto the breast properly.
Health A to Z. (n.d.). HSE.ie. https://www2.hse.ie/az/
U.S. National Library of Medicine. (n.d.). https://www.ncbi.nlm.nih.gov/
Directory Health Topics. (n.d.). https://www.healthline.com/directory/topics
Health A-Z. (2022, April 26). Verywell Health. https://www.verywellhealth.com/health-a-z-4014770
Harvard Health. (2015, November 17). Health A to Z. https://www.health.harvard.edu/health-a-to-z
Health Conditions A-Z Sitemap. (n.d.). EverydayHealth.com. https://www.everydayhealth.com/conditions/